The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Abstract
Retinal neovascularization is the major cause of untreatable blindness. The role of growth hormone (GH) in ischemia-associated retinal neovascularization was studied in transgenic mice expressing a GH antagonist gene and in normal mice given an inhibitor of GH secretion (MK678). Retinal neovascularization was inhibited in these mice in inverse proportion to serum levels of GH and a downstream effector, insulin-like growth factor–I (IGF-I). Inhibition was reversed with exogenous IGF-I administration. GH inhibition did not diminish hypoxia-stimulated retinal vascular endothelial growth factor (VEGF) or VEGF receptor expression. These data suggest that systemic inhibition of GH or IGF-I, or both, may have therapeutic potential in preventing some forms of retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Self-citationEarly Photocoagulation for Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38011-7 · Cited by 1,259
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Self-citationPhotocoagulation Treatment of Proliferative Diabetic Retinopathy
(1981) · Ophthalmology · doi:10.1016/s0161-6420(81)34978-1 · Cited by 975
Vascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Hammes, H.-P., Brownlee, M., Jonczyk, A., Sutter, A., & Preissner, K. T. (1996) · Nature Medicine · doi:10.1038/nm0596-529 · Cited by 328
(1979) · Archives of Ophthalmology · doi:10.1001/archopht.1979.01020010310003 · Cited by 302
Insulin-like Growth Factors: Studies in Diabetics with and without Retinopathy
Merimee, T. J., Zapf, J., & Froesch, E. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309013090904 · Cited by 280
Raynor, K., Murphy, W. A., Coy, D. H., Taylor, J. E., Moreau, J. P., Yasuda, K., Bell, G. I., & Reisine, T. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13664-x · Cited by 280
Cited by
Hellström, A., Smith, L. E., & Dammann, O. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60178-6 · Cited by 1,304
Self-citationClinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Frank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Connor, K. M., Krah, N. M., Dennison, R. J., Aderman, C. M., Chen, J., Guerin, K. I., Sapieha, P., Stahl, A., Willett, K. L., & Smith, L. E. H. (2009) · Nature Protocols · doi:10.1038/nprot.2009.187 · Cited by 738
Self-citationVascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., & Schwall, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624
Flynn, J. T., & Bancalari, E. (2000) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1067/mpa.2000.105823 · Cited by 620
Chen, J., & Smith, L. E. H. (2007) · Angiogenesis · doi:10.1007/s10456-007-9066-0 · Cited by 602
Self-citationHellstrom, A., Perruzzi, C., Ju, M., Engström, E., Hård, A.-L., Liu, J.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjödell, L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101113998 · Cited by 583
Self-citationInsulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Self-citationHellström, A., Engström, E., Hård, A.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Löfqvist, C., Svensson, E., Holm, S., Ewald, U., et al. (2003) · Pediatrics · doi:10.1542/peds.112.5.1016 · Cited by 526
Self-citationA1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care · doi:10.2337/dc08-0864 · Cited by 420
Retinal and choroidal neovascularization
Campochiaro, P. A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<301::aid-jcp3>3.0.co;2-h · Cited by 393
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis
Sapieha, P., Sirinyan, M., Hamel, D., Zaniolo, K., Joyal, J.-S., Cho, J.-H., Honoré, J.-C., Kermorvant-Duchemin, E., Varma, D. R., Tremblay, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1873 · Cited by 359
Stellmach, V., Crawford, S. E., Zhou, W., & Bouck, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031252398 · Cited by 355
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Self-citationOzaki, H., Seo, M.-S., Ozaki, K., Yamada, H., Yamada, E., Okamoto, N., Hofmann, F., Wood, J. M., & Campochiaro, P. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64773-6 · Cited by 347
The pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 344
Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H. S., Zack, D. J., Ettyreddy, D., et al. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1114 · Cited by 337
Signaling pathways activated by the growth hormone receptor
Herrington, J. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00423-4 · Cited by 335
Hayashi, T., Abe, K., & Itoyama, Y. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00009 · Cited by 304
Fibrosis and diseases of the eye
Friedlander, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31030 · Cited by 299
Pathogenesis of retinopathy of prematurity
Smith, L. E. H. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(03)00119-2 · Cited by 295
Self-citationAngiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life
Sapieha, P., Joyal, J.-S., Rivera, J. C., Kermorvant-Duchemin, E., Sennlaub, F., Hardy, P., Lachapelle, P., & Chemtob, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42142 · Cited by 264
Corbacho, A., Martinez De La Escalera, G., & Clapp, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730219 · Cited by 256
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Sharp, Z. D., & Bartke, A. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.293 · Cited by 122
Microvascular complications and diabetic retinopathy: recent advances and future implications
Barot, M., Gokulgandhi, M. R., Patel, S., & Mitra, A. K. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.206 · Cited by 92
Veldhuis, J. D., Bidlingmaier, M., Anderson, S. M., Evans, W. S., Wu, Z., & Strasburger, C. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011885 · Cited by 61
Metadata
- Authors
- Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M.
- Venue
- Science
- Published
- 1997-06-13
- Volume
- 276
- Issue
- 5319
- Pages
- 1706-1709
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2055696255
- Cited by
- 393
- References
- 23
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.